Future DTC drug ads will be hyper-targeted

04/2/2012 | Medical Marketing & Media

As big pharma's focus shifts from creating blockbusters to developing biologic drugs and other niche products, drug marketing will become more narrow, targeted and multifaceted, writes Matthew Arnold. For example, AbelsonTaylor's campaign for Pfizer and Amgen's Enbrel features a celebrity spokesman, but a separate campaign for the therapy targets patients with plaque psoriasis. New measurement and analysis tools, as well as consumer channels, allow marketers to reach potential patients with more precision, experts say.

View Full Article in:

Medical Marketing & Media

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX